Dr. Stough is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3633 Central Ave
Ste N
Hot Springs, AR 71913Phone+1 501-623-6100Fax+1 501-623-6187
Summary
- Board certified Dermatologist with an interest in research and development of dermatology prescription and OTC products. Co-founder of Burke Therapeutics-specializing in prescription dermatology products, and Certified Physician Investigator.
www.burketherapeutics.com
Education & Training
- University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Dermatology, 1985 - 1988
- University of TennesseeResidency, Internal Medicine, 1984 - 1985
- University of Arkansas For Medical Sciences College of MedicineClass of 1984
Certifications & Licensure
- AR State Medical License 1984 - 2025
- TX State Medical License 1988 - 2024
- NY State Medical License 1998 - 2022
- FL State Medical License 2009 - 2015
- OK State Medical License 2010 - 2014
- TN State Medical License 1994 - 2011
- American Board of Dermatology Dermatology
Clinical Trials
- A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis Start of enrollment: 2018 Jan 30
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
Roles: Principal Investigator
Publications & Presentations
PubMed
- 8 citationsPharmacokinetics of ingenol mebutate gel under maximum use conditions in large treatment areas.Alicia D. Bucko, Michael Jarratt, Dowling B Stough, Laerke Kyhl, John Villumsen
The Journal of Dermatological Treatment. 2018-01-02 - 88 citationsClinical dose ranging studies with finasteride, a type 2 5α-reductase inhibitor, in men with male pattern hair lossJanet L. Roberts, Virginia C. Fiedler, Julianne Imperato-McGinley, David A. Whiting, Elise A. Olsen
Journal of the American Academy of Dermatology. 1999-10-01 - 47 citationsTreatment of keratoacanthomas with intralesional methotrexateJeffrey L. Melton, Bruce R. Nelson, Dowling B. Stough, Marc D. Brown, Neil A. Swanson
Journal of the American Academy of Dermatology. 1991-12-01
Journal Articles
- Electroporation Therapy of Skin Cancer in the Head and Neck AreaDermatologic Surgery, 1/1/2011
- Fluorouracil Cream 05% for Actinic Keratoses on Multiple Body Sites: An 18-Month Open-Label StudyCutis, 1/1/2010
- The Institutional Review Board-Watching GINA Waive her RightsThe Monitor, 1/1/2010
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Safety and Efficacy of Fluorouracil Cream 0.5% for Treatment of Actinic Keratoses on Body Sites Other Than the Face12th World Congress on Cancers of the Skin (WCCS), Sanofi-aventis , Tel Aviv, Israel, 1/3/2009
- Comparison of Spinosad versus Permethrin Treatments for Pediculosis Capitis in Children and AdultsPediatrics, 1/1/2009
- Safety and Efficacy of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses on Body Sites other than the FaceAmerican Society of Dermatologic Surgery, Orlando, FL, 1/6/2008
- Join now to see all
Lectures
- Follicular Unit Hair Transplantation for Men & WomenAtlanta, GA - 1/10/2012
- New Treatments for Head LiceLittle Rock, AR - 1/14/2011
- Is that Rash Infectious?Little Rock, AR - 1/14/2011
- Join now to see all
Other
- Core Competencies for Hair Restoration Surgeons Recommended by the International Society of Hair Restoration SurgeryDermatologic Surgery
1/1/2009 - 5-Alpha Reductase Inhibitors: More Questions, Less ConcernsHair Transplant Forum International
1/1/2008 - Needlestick Injuries: RisksHair Transplant Forum International
1/1/2007 - Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: